This document discusses community pharmacy practice and the implementation of professional pharmacy services. It provides statistics on community pharmacies and pharmacists in different countries. It then outlines frameworks for implementing services, including preparation, testing, and sustainability stages. Professional services discussed include disease management, participating in therapeutic decisions, and medication reviews. The justification given for further research is the need to understand real-world implementation challenges. The objectives are to analyze implementation frameworks, explore the implementation process in pharmacies, and develop tools to measure implementation outcomes like fidelity.
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...Marion Sills
Kwan BM, Sills MR, Graham D, Hamer MK, Fairclough DL, Hammermeister KE, Kaiser A, Diaz-Perez MJ, Schilling LM. Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Practice-Based Research Network. JABFM. In Press.
NONPF - 1NURSE PRACTITIONER CORE COMPETENCIES April 201.docxkendalfarrier
NONPF - 1
NURSE PRACTITIONER CORE COMPETENCIES
April 2011
Amended 2012*
Task Force Members
Anne C. Thomas, PhD, ANP-BC, GNP - Chair
M. Katherine Crabtree, DNSc, FAAN, APRN-BC
Kathleen R. Delaney, PhD, PMH-NP
Mary Anne Dumas, PhD, RN, FNP-BC, FAANP
Ruth Kleinpell, PhD, RN, FAAN, FCCM
M. Cynthia Logsdon, PhD, WHNP-BC, FAAN
Julie Marfell, DNP, FNP-BC, FAANP
Donna G. Nativio, PhD, CRNP, FAAN
Note: Terms in bold are defined within the glossary found at the end of the competencies.
Preamble
In August 2008, NONPF endorsed the evolution of the Doctorate of Nursing Practice (DNP) as the entry
level for nurse practitioner (NP) practice (NONPF, 2008a). Nurse practitioner education, which is based
upon the NONPF competencies, recognizes that the student’s ability to show successful achievement of
the NONPF competencies for NP education is of greater value than the number of clinical hours the
student has performed (NONPF, 2008b).
The Nurse Practitioner Core Competencies (NP Core Competencies) integrate and build upon existing
Master’s and DNP core competencies and are guidelines for educational programs preparing NPs to
implement the full scope of practice as a licensed independent practitioner. The competencies are
essential behaviors of all NPs. These competencies are demonstrated upon graduation regardless of the
population focus of the program and are necessary for NPs to meet the complex challenges of translating
rapidly expanding knowledge into practice and function in a changing health care environment.
Nurse Practitioner graduates have knowledge, skills, and abilities that are essential to independent
clinical practice. The NP Core Competencies are acquired through mentored patient care experiences
with emphasis on independent and interprofessional practice; analytic skills for evaluating and
providing evidence-based, patient centered care across settings; and advanced knowledge of the
health care delivery system. Doctorally-prepared NPs apply knowledge of scientific foundations in
practice for quality care. They are able to apply skills in technology and information literacy, and engage
in practice inquiry to improve health outcomes, policy, and healthcare delivery. Areas of increased
knowledge, skills, and expertise include advanced communication skills, collaboration, complex decision
making, leadership, and the business of health care. The competencies elaborated here build upon
previous work that identified knowledge and skills essential to DNP competencies (AACN 1996; AACN,
2006; NONPF & National Panel, 2006) and are consistent with the recommendations of the Institute of
Medicine’s report, The Future of Nursing (IOM, 2011).
At completion of the NP program, the NP graduate possesses the nine (9) core competencies regardless
of population focus.
* Amended as result of additional validation through the 2011-2012 Population-Focused Competencies Task Force.
Competencies 7, 6, & 7 .
Encouraging best practice and improve the rational use of medicinesMeTApresents
This presentation looks at the priorities for the work of the Medicines Transparency Alliance (MeTA) Jordan Council. It was made by Dr Lama Al Homoud at the launch of MeTA Jordan in May 2009
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...Marion Sills
Kwan BM, Sills MR, Graham D, Hamer MK, Fairclough DL, Hammermeister KE, Kaiser A, Diaz-Perez MJ, Schilling LM. Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Practice-Based Research Network. JABFM. In Press.
NONPF - 1NURSE PRACTITIONER CORE COMPETENCIES April 201.docxkendalfarrier
NONPF - 1
NURSE PRACTITIONER CORE COMPETENCIES
April 2011
Amended 2012*
Task Force Members
Anne C. Thomas, PhD, ANP-BC, GNP - Chair
M. Katherine Crabtree, DNSc, FAAN, APRN-BC
Kathleen R. Delaney, PhD, PMH-NP
Mary Anne Dumas, PhD, RN, FNP-BC, FAANP
Ruth Kleinpell, PhD, RN, FAAN, FCCM
M. Cynthia Logsdon, PhD, WHNP-BC, FAAN
Julie Marfell, DNP, FNP-BC, FAANP
Donna G. Nativio, PhD, CRNP, FAAN
Note: Terms in bold are defined within the glossary found at the end of the competencies.
Preamble
In August 2008, NONPF endorsed the evolution of the Doctorate of Nursing Practice (DNP) as the entry
level for nurse practitioner (NP) practice (NONPF, 2008a). Nurse practitioner education, which is based
upon the NONPF competencies, recognizes that the student’s ability to show successful achievement of
the NONPF competencies for NP education is of greater value than the number of clinical hours the
student has performed (NONPF, 2008b).
The Nurse Practitioner Core Competencies (NP Core Competencies) integrate and build upon existing
Master’s and DNP core competencies and are guidelines for educational programs preparing NPs to
implement the full scope of practice as a licensed independent practitioner. The competencies are
essential behaviors of all NPs. These competencies are demonstrated upon graduation regardless of the
population focus of the program and are necessary for NPs to meet the complex challenges of translating
rapidly expanding knowledge into practice and function in a changing health care environment.
Nurse Practitioner graduates have knowledge, skills, and abilities that are essential to independent
clinical practice. The NP Core Competencies are acquired through mentored patient care experiences
with emphasis on independent and interprofessional practice; analytic skills for evaluating and
providing evidence-based, patient centered care across settings; and advanced knowledge of the
health care delivery system. Doctorally-prepared NPs apply knowledge of scientific foundations in
practice for quality care. They are able to apply skills in technology and information literacy, and engage
in practice inquiry to improve health outcomes, policy, and healthcare delivery. Areas of increased
knowledge, skills, and expertise include advanced communication skills, collaboration, complex decision
making, leadership, and the business of health care. The competencies elaborated here build upon
previous work that identified knowledge and skills essential to DNP competencies (AACN 1996; AACN,
2006; NONPF & National Panel, 2006) and are consistent with the recommendations of the Institute of
Medicine’s report, The Future of Nursing (IOM, 2011).
At completion of the NP program, the NP graduate possesses the nine (9) core competencies regardless
of population focus.
* Amended as result of additional validation through the 2011-2012 Population-Focused Competencies Task Force.
Competencies 7, 6, & 7 .
Encouraging best practice and improve the rational use of medicinesMeTApresents
This presentation looks at the priorities for the work of the Medicines Transparency Alliance (MeTA) Jordan Council. It was made by Dr Lama Al Homoud at the launch of MeTA Jordan in May 2009
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay.
Assessment of Good Pharmacy Practice (GPP) in Pharmacies of Community Setting...iosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
Clinical Audit is a method of confirming the quality of clinical services and identify the need for improvement. A skill hospital administrator should learn and practice.
Chapter 7. The Evidence for Evidence-Based Practice Implem.docxspoonerneddy
Chapter 7. The Evidence for Evidence-Based Practice
Implementation
Marita G. Titler
Background
Overview of Evidence-Based Practice
Evidence-based health care practices are available for a number of conditions such as asthma,
heart failure, and diabetes. However, these practices are not always implemented in care
delivery, and variation in practices abound.1–4 Traditionally, patient safety research has focused
on data analyses to identify patient safety issues and to demonstrate that a new practice will lead
to improved quality and patient safety.5 Much less research attention has been paid to how to
implement practices. Yet, only by putting into practice what is learned from research will care be
made safer.5 Implementing evidence-based safety practices are difficult and need strategies that
address the complexity of systems of care, individual practitioners, senior leadership, and—
ultimately—changing health care cultures to be evidence-based safety practice environments.5
Nursing has a rich history of using research in practice, pioneered by Florence Nightingale.6–
9 Although during the early and mid-1900s, few nurses contributed to this foundation initiated
by Nightingale,10 the nursing profession has more recently provided major leadership for
improving care through application of research findings in practice.11
Evidence-based practice (EBP) is the conscientious and judicious use of current best
evidence in conjunction with clinical expertise and patient values to guide health care
decisions.12–15 Best evidence includes empirical evidence from randomized controlled trials;
evidence from other scientific methods such as descriptive and qualitative research; as well as
use of information from case reports, scientific principles, and expert opinion. When enough
research evidence is available, the practice should be guided by research evidence in conjunction
with clinical expertise and patient values. In some cases, however, a sufficient research base may
not be available, and health care decisionmaking is derived principally from nonresearch
evidence sources such as expert opinion and scientific principles.16 As more research is done in a
specific area, the research evidence must be incorporated into the EBP.15
Models of Evidence-Based Practice
Multiple models of EBP are available and have been used in a variety of clinical settings.16–36
Although review of these models is beyond the scope of this chapter, common elements of these
models are selecting a practice topic (e.g., discharge instructions for individuals with heart
failure), critique and syntheses of evidence, implementation, evaluation of the impact on patient
care and provider performance, and consideration of the context/setting in which the practice is
implemented.15, 17 The learning that occurs during the process of translating research into
practice is valuable information to capture and feed back into the process, so that.
Chapter 7. The Evidence for Evidence-Based Practice Implem.docxmccormicknadine86
Chapter 7. The Evidence for Evidence-Based Practice
Implementation
Marita G. Titler
Background
Overview of Evidence-Based Practice
Evidence-based health care practices are available for a number of conditions such as asthma,
heart failure, and diabetes. However, these practices are not always implemented in care
delivery, and variation in practices abound.1–4 Traditionally, patient safety research has focused
on data analyses to identify patient safety issues and to demonstrate that a new practice will lead
to improved quality and patient safety.5 Much less research attention has been paid to how to
implement practices. Yet, only by putting into practice what is learned from research will care be
made safer.5 Implementing evidence-based safety practices are difficult and need strategies that
address the complexity of systems of care, individual practitioners, senior leadership, and—
ultimately—changing health care cultures to be evidence-based safety practice environments.5
Nursing has a rich history of using research in practice, pioneered by Florence Nightingale.6–
9 Although during the early and mid-1900s, few nurses contributed to this foundation initiated
by Nightingale,10 the nursing profession has more recently provided major leadership for
improving care through application of research findings in practice.11
Evidence-based practice (EBP) is the conscientious and judicious use of current best
evidence in conjunction with clinical expertise and patient values to guide health care
decisions.12–15 Best evidence includes empirical evidence from randomized controlled trials;
evidence from other scientific methods such as descriptive and qualitative research; as well as
use of information from case reports, scientific principles, and expert opinion. When enough
research evidence is available, the practice should be guided by research evidence in conjunction
with clinical expertise and patient values. In some cases, however, a sufficient research base may
not be available, and health care decisionmaking is derived principally from nonresearch
evidence sources such as expert opinion and scientific principles.16 As more research is done in a
specific area, the research evidence must be incorporated into the EBP.15
Models of Evidence-Based Practice
Multiple models of EBP are available and have been used in a variety of clinical settings.16–36
Although review of these models is beyond the scope of this chapter, common elements of these
models are selecting a practice topic (e.g., discharge instructions for individuals with heart
failure), critique and syntheses of evidence, implementation, evaluation of the impact on patient
care and provider performance, and consideration of the context/setting in which the practice is
implemented.15, 17 The learning that occurs during the process of translating research into
practice is valuable information to capture and feed back into the process, so that ...
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay.
Assessment of Good Pharmacy Practice (GPP) in Pharmacies of Community Setting...iosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
Clinical Audit is a method of confirming the quality of clinical services and identify the need for improvement. A skill hospital administrator should learn and practice.
Chapter 7. The Evidence for Evidence-Based Practice Implem.docxspoonerneddy
Chapter 7. The Evidence for Evidence-Based Practice
Implementation
Marita G. Titler
Background
Overview of Evidence-Based Practice
Evidence-based health care practices are available for a number of conditions such as asthma,
heart failure, and diabetes. However, these practices are not always implemented in care
delivery, and variation in practices abound.1–4 Traditionally, patient safety research has focused
on data analyses to identify patient safety issues and to demonstrate that a new practice will lead
to improved quality and patient safety.5 Much less research attention has been paid to how to
implement practices. Yet, only by putting into practice what is learned from research will care be
made safer.5 Implementing evidence-based safety practices are difficult and need strategies that
address the complexity of systems of care, individual practitioners, senior leadership, and—
ultimately—changing health care cultures to be evidence-based safety practice environments.5
Nursing has a rich history of using research in practice, pioneered by Florence Nightingale.6–
9 Although during the early and mid-1900s, few nurses contributed to this foundation initiated
by Nightingale,10 the nursing profession has more recently provided major leadership for
improving care through application of research findings in practice.11
Evidence-based practice (EBP) is the conscientious and judicious use of current best
evidence in conjunction with clinical expertise and patient values to guide health care
decisions.12–15 Best evidence includes empirical evidence from randomized controlled trials;
evidence from other scientific methods such as descriptive and qualitative research; as well as
use of information from case reports, scientific principles, and expert opinion. When enough
research evidence is available, the practice should be guided by research evidence in conjunction
with clinical expertise and patient values. In some cases, however, a sufficient research base may
not be available, and health care decisionmaking is derived principally from nonresearch
evidence sources such as expert opinion and scientific principles.16 As more research is done in a
specific area, the research evidence must be incorporated into the EBP.15
Models of Evidence-Based Practice
Multiple models of EBP are available and have been used in a variety of clinical settings.16–36
Although review of these models is beyond the scope of this chapter, common elements of these
models are selecting a practice topic (e.g., discharge instructions for individuals with heart
failure), critique and syntheses of evidence, implementation, evaluation of the impact on patient
care and provider performance, and consideration of the context/setting in which the practice is
implemented.15, 17 The learning that occurs during the process of translating research into
practice is valuable information to capture and feed back into the process, so that.
Chapter 7. The Evidence for Evidence-Based Practice Implem.docxmccormicknadine86
Chapter 7. The Evidence for Evidence-Based Practice
Implementation
Marita G. Titler
Background
Overview of Evidence-Based Practice
Evidence-based health care practices are available for a number of conditions such as asthma,
heart failure, and diabetes. However, these practices are not always implemented in care
delivery, and variation in practices abound.1–4 Traditionally, patient safety research has focused
on data analyses to identify patient safety issues and to demonstrate that a new practice will lead
to improved quality and patient safety.5 Much less research attention has been paid to how to
implement practices. Yet, only by putting into practice what is learned from research will care be
made safer.5 Implementing evidence-based safety practices are difficult and need strategies that
address the complexity of systems of care, individual practitioners, senior leadership, and—
ultimately—changing health care cultures to be evidence-based safety practice environments.5
Nursing has a rich history of using research in practice, pioneered by Florence Nightingale.6–
9 Although during the early and mid-1900s, few nurses contributed to this foundation initiated
by Nightingale,10 the nursing profession has more recently provided major leadership for
improving care through application of research findings in practice.11
Evidence-based practice (EBP) is the conscientious and judicious use of current best
evidence in conjunction with clinical expertise and patient values to guide health care
decisions.12–15 Best evidence includes empirical evidence from randomized controlled trials;
evidence from other scientific methods such as descriptive and qualitative research; as well as
use of information from case reports, scientific principles, and expert opinion. When enough
research evidence is available, the practice should be guided by research evidence in conjunction
with clinical expertise and patient values. In some cases, however, a sufficient research base may
not be available, and health care decisionmaking is derived principally from nonresearch
evidence sources such as expert opinion and scientific principles.16 As more research is done in a
specific area, the research evidence must be incorporated into the EBP.15
Models of Evidence-Based Practice
Multiple models of EBP are available and have been used in a variety of clinical settings.16–36
Although review of these models is beyond the scope of this chapter, common elements of these
models are selecting a practice topic (e.g., discharge instructions for individuals with heart
failure), critique and syntheses of evidence, implementation, evaluation of the impact on patient
care and provider performance, and consideration of the context/setting in which the practice is
implemented.15, 17 The learning that occurs during the process of translating research into
practice is valuable information to capture and feed back into the process, so that ...
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
1. PREPARED BY:
AJIT KUMAR VARMA
Asst. Professor,
Faculty of Pharmaceutical Sciences,
RAMA UNIVERSITY , KANPUR-209217
COMMUNITY PHARMACY PRACTICE
2. COMMUNITY PHARMACY
~ 47 million population
21 854 community pharmacies
68 381 pharmacists
~ 2 150 people/pharmacy
~ 3.1 pharmacists/
pharmacy
~ 23 million population
5 457 community pharmacies
28 950 pharmacists
~ 4 300 people/pharmacy
~ 5.3 pharmacists/pharmacy
~ 8 million population
1 744 community pharmacies
~ 4 300 pharmacists
~ 4 600 people/pharmacy
~ 2.5 pharmacists/
pharmacy
3. Westfall J., Mold J., Fagna, L. JAMA 2007. 297(4):403-406.
EVIDENCE PATHWAY
Awareness
Sustainment
Service
Definition
Evaluation
Communication
4. PROFESSIONAL PHARMACY SERVICES
8.
9.
Disease State Management for Chronic Conditions
Participation in Therapeutic Decisions with Medical Practitioners
Hierarchical Model of Cognitive Pharmaceutical Services
1. Medicines Information
2. Compliance, adherence and/or concordance
3. Disease screening
4. Disease prevention
5. Clinical intervention or drug related problems
6. Medication Use Reviews (MUR)
7. Medication Management/Medication Therapy Management
a. Home Medication Review (HMR)
b. Residential Care Medication Reviews (RMMR)
c. Medication Review with follow-up (Seguimiento Farmacoterapéutico, SFT)
a. Clinical setting
b. Pharmacy setting
10. Prescribing
a. Supplementary
b. Dependent
5. MEDICATION REVIEW
Aim defined
Types classified
Clinical effectiveness studied
Cost-effectiveness studied
X Fidelity of provision
X Reach including representativeness
X Degree of integration into practice
X Cost of implementation
X Effectiveness of implementation strategies
We don´t know the “real World” situation
6. Westfall J., Mold J., Fagna, L. JAMA 2007. 297(4):403-406.
EVIDENCE PATHWAY
Definition
Evaluation
Communication
Service
Awareness
Sustainment
Gap
7. JUSTIFICATIO
N
• There is an international movement towards the development, diffusion,
implementation and sustainability of professional pharmacy services, however there
appears to be an pervasive struggle to achieving widespread integration into routine
practice.1
• There appears to be no theoretical framework that incorporates all the elements that
are involved in the implementation process in the community pharmacy setting.2
• Together with a theoretical framework there is a need for a model for the evaluation to
be designed to assess the implementation and provision of such services.3
• A practical application of implementation frameworks, models and tools for the
implementation of professional pharmacy services is to provide researchers,
academics, professional organisations and pharmacists a base from which to develop
implementation protocols and programs.
• Implementation evidence may help community pharmacy achieve their overall goal of
professional service provision and subsequent improvement of health outcomes for
the communities they serve.
1
8. OBJECTIVES
Specific Objectives
1. Identify the extent to which existing implementation frameworks include
implementation concepts and determine if frameworks vary depending on the
innovation they target.
2. Explore the implementation process occurring in community pharmacy and to
assess the factors, strategies and evaluations influencing this process, in order to
tailor a framework for the implementation of services in pharmacy.
3. Develop two tools to measure fidelity, specifically an adherence index and a
patient responsiveness scale for medication review with follow-up service.
The thesis covered the synthesis, analysis and progression of knowledge
concerning implementation science as well as its contextualisation and
application for the implementation of professional services in community
internationally. The research conceptualised and defined the process,
influences and indicators for the implementation of professional pharmacy
services in community pharmacy.
9. Sequence Methodology Article
Delineate the implementation
process into a series of stages and
activities
1
Define Professional Pharmacy
Services
Semi-structured interviews
Categorise levels that influence
implementation in pharmacy
Propose factors, strategies, and
evaluations implicated in
implementation
Design measures to conduct
implementation research and
projects
Quantitative study
Determine the concepts involved in
the implementation of an
innovation in healthcare
2
5
Systematic Literature review
3
Theoretical work
Theoretical work 4
10. Pharmacy Services
Professional
Pharmacy Services
Pharmaceutical
Services
Pharmacist Services
Other Healthcare
Services
Other Healthcare
Practitioner Services
Non-professional
Pharmacy Services
Professional Pharmacy Service
…is an action or set of actions undertaken in or organised by a
pharmacy, delivered by a pharmacist or other health practitioner, who
applies their specialised health knowledge personally or via an
intermediary, with a patient/client, population or other health
professional, to optimise the process of care, with the aim to improve
health outcomes and the value of healthcare.
Moullin, JC., Sabater-Hernández, D., Fernandez-Llimos, F., Benrimoj, SI. Res Social Adm Pharm 2013 Nov-Dec; 9(6): 989-995
Pharmacy Services
RESULTS
12. METHODOLO
GY
Objetive 1: Identify the extent to which existing implementation
frameworks include implementation concepts and determine if frameworks
vary depending on the innovation they target
Systematic literature review to explore implementation science and collate the
results as a Generic Implementation Framework
A systematic search was undertaken in PubMed to identify implementation
frameworks of innovations in healthcare published from 2004 (post a
comprehensive literature review of implementation studies conducted by
Greenhalgh et al (2004)) to May 2013.
In addition titles and abstracts from Implementation Science journal and
references from identified papers were reviewed.
The orientation, type, presence of stages and domains, along with the degree of
inclusion and depth of analysis of factors, strategies and evaluations of
implementation of included frameworks were analysed.
13. There is variability in the concepts included and the depth of their exploration
within implementation frameworks of diverse innovations in healthcare.
Out of the 49 implementation frameworks only five comprehensively included the
range of items within any one element with justification for their inclusion.
Overall, there was limited degree and depth of analysis of implementation
concepts.
Generic Implementation Framework
RESULTS
Moullin, J.C., Sabater‐Hernández D, Fernandez-Llimos F, Benrimoj SI 2015. Health Res Policy Syst, vol. 13, p. 16.
14. GENERIC IMPLEMENTATION
FRAMEWORK (GIF)
Moullin, J.C., Sabater‐Hernández D, Fernandez-Llimos F, Benrimoj SI 2015. Health Res Policy Syst, vol. 13, p. 16.
Six core concepts of implementation
Implementation involves
(1) an innovation,
(2) a multi-level context,
(3) a complex multi-stage process,
Influenced by a range of
(4) factors
(5) strategies
(6) and evaluations (formative and summative).
15. Determine the concepts involved in
the implementation of an innovation
in healthcare
2
Systematic Literature review
Sequence Methodology Article
16. METHODOLOG
Y
Objective 2: Explore the implementation process occurring in community
pharmacy and to assess the factors, strategies and evaluations influencing
this process, in order to tailor a framework for the implementation of services
in pharmacy
A qualitative study using semi-structured interviews to examine the process and
influences on implementation in community pharmacies in Australia.
Setting: 21 community pharmacies in Australia
Population: 25 pharmacists
Study Design: Semi-structured interviews using an eight question interview guide
based on the implementation concepts from the literature review
Analysis: Framework analysis and thematic analysis of the data
Ethics approval was obtained and all participants signed consent forms. All responses were
confidential.
17. RESULTS
Preparation
Operation
Exploration
Assess:
- Organisational fit
- V
alue (relative
advantage)
- Service(characteristics)
- Organisational capacity
Sustainability
- Monitoring*
- Adaptation*
- Improvement*
staff capacity)
- Community fit
Decision
- Initial adaptations
- Familiarisation &
improvestaff conditions
- T
est patient demand
Testing
- Modification of
plans &procedures
- Maintain patient
demand
- Staffing
- T
eamwork, team
input, &internal
communication
- Integration tactics
- Ongoing training
- Goal setting
- Monitoring
- Adaptation
- Improvement
- Assignleader
(supporting conditions & - Research requirements
- Organise supporting
conditions
- Plan serviceprocedure
- Rearrange workflow
- Staff arrangements
- T
eamcommunication
(buy-in&foster climate)
- Training
- Community awareness
&recruitment
Development or
Discovery
Trigger
18. RESULTS
Moullin, J.C., Sabater‐Hernández D, Benrimoj SI. Results under review.
Influences: Factors, strategies and evaluations
Service value/relative advantage and characteristics crucial
Five key drivers appeared across all implementation stages, plus the service
• Pharmacy's direction and impetus
• Internal communication
• Staffing
• Community fit
• Support
Seventeen new factors added to CFIR
Strategies varied widely
Evaluations were lacking
19. RESULTS
Stages
Exploration Preparation Testing Operation Sustainability
1 Trigger
2 Pharmacy direction & impetus
3 Value & relative advantage
4 Service characteristics
5 Supporting conditions
6 Staff capacity
7 Community fit
8 Team input and teamwork
9 Internal communication
10 Service procedure
11 Training
12 Goal setting
13 Behavioural regulation
14 Adaptations
15 Improvement
16 Evaluation
20. FRAMEWORKS
- Active Implementation Frameworks
- Promoting Action on Research Implementation in Health Services (PARIHS)
- Consolidated Framework for Implementation Research (CFIR)
- Theoretical Domains Framework (TDF) & Behaviour Change Wheel (BCW)
- Quality Implementation Framework
- RE-AIM
Generic Implementation Framework
Framework for the Implementation of Services in Pharmacy
1. Model of the implementation process in community pharmacy (stages & steps)
2. Contextual ecological levels of influence for community pharmacy
3. Adapted CFIR list of influencing factors for community pharmacy
4. Implementation Strategies
5. Model for the evaluation of implementation programs and professional pharmacy services
22. Results under review
Delineate the implementation
process into a series of stages and
activities
Semi-structured interviews
Categorise levels that influence
implementation in pharmacy
Propose factors, strategies, and
evaluations implicated in
implementation
3
Sequence Methodology Article
23. MODEL FOR THE EVALUATION OF
IMPLEMENTATION PROGRAMS AND
PHARMACY SERVICES
Moullin JC, Sabater-Hernández D, Benrimoj SI:. Res Social Adm Pharm 2015. [ePub 15 Aug 2015].
24. Level of service provision
- Reach
- Fidelity
PHARMACY LEVEL
OF SERVICE
IMPLEMENTATION
(MESO)
Level as service provider
- Service integration
- Local perception
(patient, community &
healthcare professionals)
Level of service provision
- Reach
- Fidelity
Level as service provider
- Stage attainment
- System support
SYSTEM LEVEL
OF SERVICE
IMPLEMENTATION
(MACRO)
Level of service provision
- Reach
- Fidelity
PHARMACIST LEVEL
OF SERVICE
IMPLEMENTATION
(MICRO)
Level as service provider
- Service integration
- Staff perception
LEVEL OF IMPLEMENTATION
25. Propose factors, strategies, and
evaluations implicated in
implementation
Theoretical work 4
Sequence Methodology Article
26. METHODOLOGY
Objective 3: Develop two tools to measure fidelity, specifically an
adherence index and a patient responsiveness scale for medication review
with follow-up service.
Mixed methodology study, using both an expert panel followed by statistical
analysis, conducted in Spain, to develop two questionnaires and test their
reliability and validity as measures of the implementation outcome, fidelity.
Expert panel used to establish content validity of both tools
Initial item functioning for both tools was conducted using descriptive statistics and
item discrimination
Cronbach’s alpha and inter-item for reliability of the scale
Exploratory Factor Analysis (EFA) to test construct validity of the scale
Ethics approval was obtained and all participants signed consent forms. All responses were
confidential.
27. RESULTS
Fidelity
Conceptual variable Operational definition
Adherence (6-8, 19, 20) Process: The extent service delivery is consistent with the designed service
process and protocol.
Structure: The extent to which the environmental aspects and foundation
from which the service is delivered are implemented.
Dose (6-8, 19, 20) The amount (intensity), frequency and duration of service components and
phases.
Patient responsiveness (7, 19, 20) Degree of patient participation and enthusiasm to aspects of the service
protocol that require their involvement.
Adaptation* (6, 19) Unintentional drift or intended changes made to the components of the
service
Quality* (6-8, 19, 20) The manner in which the service is delivered towards the theoretical ideal.
Dimensions may include provider enthusiasm, facilitation of responsiveness,
preparation, knowledge and confidence/self-efficacy.
Differentiation* (6-8, 19, 20) Degree to which the critical components are present including comparing
what patients receive with the service to what they receive with normal
practice.
* Conceptual variables that may not be considered dimensions of fidelity, but as moderators.
They should be measured, but may or may not be included in fidelity measurement itself (8)
28. PATIENT RESPONSIVENESS SCALE
• Degree patients respond to aspects of the
service protocol that require their involvement.
• Item pool was built
• 5-point Likert scale to indicate the frequency
ADHERENCE INDEX
• Measure the adherence to the process
aspects of all phases of the service
• Items for each phase were delineated
considering the definition and objectives of
the service
• 5-point Likert scale to indicate the frequency
- FIDELITY -
1) Define the latent
variable
2) Generate
indicators/items
3) Determine format
for measurement
4) Expert review of
items
5) Administer to
sample
6) Evaluate items
7) Optimise length
30. PATIENT RESPONSIVENESS SCALE
- Content validated and acceptability high
- Low discrimination. Response format changed
- Innovation specific until core components are
compared across innovations
- Indicator collinearity and external validity
testing is required
ADHERENCE INDEX
- Content validated and acceptability high
- Reliability and construct validity tested
- Two factor solution
- 4 items removed after 5 EFA iterations
- Participation (9 items) & enthusiasm (3 items)
- FIDELITY -
1) Define the latent
variable
2) Generate
indicators/items
3) Determine
format for
measurement
4) Expert review of
items
5) Administer to
sample
6) Evaluate items
7) Optimise length
3) Determine format
for measurement
4) Expert review of
items
5) Administer to
sample
6) Evaluate items
7) Optimise length
32. PATIENT RESPONSIVENESS SCALE
Moullin, J.C., Sabater‐Hernández D, García-Corpas J.P., Kenny P., Benrimoj S.I., 2015. J Eval Clin Pract. Fothcoming
- FIDELITY -
Never
[1]
Rarely
[2]
Sometimes
[3]
Often
[4]
Always
[5]
1 Patients request the service.
2 Patients take the initiative to ask the pharmacist questions.
3 Patients provide information about all the medicines they use.
4 Patients actively participate in the encounters with the pharmacist.
5 Patients collaborate in deciding upon and implementing an action plan.
6 Patients comply with the interventions proposed by the pharmacist.
7
Patients adhere to changes in the medication regimen (change in medication, dose,
schedule etc.)
8
Patients adhere to educational interventions (e.g. use of medications, adherence,
non-pharmacologicaladvice etc.)
9 Patients go to the doctor when the pharmacist recommends them to do so.
10 Patients keep the pharmacist informed of any changes in medication or health status.
11 Patients come to appointments scheduled by the pharmacist.
12 Patients´ family and friends talk about the benefits of the service.
33. Design measures to conduct
implementation research and
projects
Quantitative study 5
Accepted and Forthcoming
J Eval Clin Pract
Sequence Methodology Article
34. RESEARCH DISSEMINATION
SUMMARY
Peer Reviewed Publications
2015 Moullin JC et al. Model for evaluation of implementation programs and
professional pharmacy services. Res Social Adm Pharm. Epub 2015 Aug 15.
2015 Moullin JC et al. Development and testing of two implementation tools to
measure components of professional pharmacy service fidelity. J Eval Clin Pract.
Forthcoming 2015.
2015 Moullin JC et al. Qualitative study on the implementation of professional
pharmacy services in community pharmacy using framework analysis. (results
under review)
2015 Moullin JC et al. A systematic review of implementation frameworks of
innovations in healthcare and resulting generic implementation framework.
Health Res Policy Syst 2015; 13:16.
2013 Moullin JC et al. Defining Professional Pharmacy Services in Community
Pharmacy. Res SocialAdm Pharm 2013; 9(6): 989-995.
35. APPLICATIO
N
• Health Destination Pharmacy
• AIM-HIGH (adherence program for banner group of pharmacies)
• conSIGUE (medication review with follow-up in Spain)
• Asthma program
37. 1. Exploration 2. Prep. 3. Implementation
4a. Initial
sustainability
Systems
interventions
Facilitator
training
5 days
Pharmacy
owner
training
2 Days
Deliverer
(pharmacist)
Training
3 Days
Facilitation Internal
champion
Facilitation Internal
Champion
Audit and
feedback
Audit and
feedback
Needs
assessment
Barrier and
facilitator
assessment
System
change
On-site
assessment
and
education
Service
adaptation
Behavioural
change
Organisation
change
Strategies
Strategies
38. Evaluations
Stage:
Adoption
No. pharmacies
deciding to
adopt SFT
Stage: Initial
implementation
No. pharmacies
initiated SFT delivery
Stage: Initial
Sustainability
No. of pharmacies
continued SFT
delivery to target
number of patients
1. Exploration 2. Prep. 3. Implementation
4a. Initial
Sustainability
Owner
training
evaluation
Pharmacist
Training
evaluation
Champion
evaluation
Program
evaluation
Program
evaluatio
n
Implementation
Reach: Number of SFT services delivered
Service Benefits: Economic, Clinical and Humanistic
Stage: Full
implementation
No. of pharmacies
continued SFT
delivery to target
number of patients
Facilitator
training
evaluation
Facilitator
and
facilitation
evaluation
Facilitator
and
facilitation
evaluation
Fidelity
Process & structure
indicators of SFT &
implementation
Integration
Routine delivery
and established
support
Fidelity
Process & structure
indicators of SFT &
implementation
Integration
Routine delivery
and established
support
Fidelity
Process & structure
indicators of SFT &
implementation
Integration
Routine delivery
and established
support
Service
evaluation
evaluation